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Introduction. Patients with degenerative hip disease frequently present with bilateral involvement that requires surgical
management. The main goal when treating these patients is to achieve the maximum efficiency without increasing risk of
perioperative complications; therefore, the decision regarding the best moment to operate the second hip becomes relevant.
Although studies have addressed this topic, whether a simultaneous or staged surgery should be performed remains controversial.
The purpose of this study was to determine, based on available evidence, the optimum strategy in terms of safety to operate the
second hip in patients with bilateral involvement.Materials and Methods. A meta-analysis was planned. A systematic review of the
literature was performed including clinical trials or observational analytical studies comparing the safety of bilateral arthroplasty
performed simultaneously or staged by measuring major and minor complications. The appropriateness of a meta-analysis was
evaluated through the detailed analysis of the risk of bias and clinical heterogeneity of the included studies. Results. Thirteen
studies were selected after the systematic review. A wide variability in the methodological designs was found with a critical risk
of bias in most of them. Considerable heterogeneity was detected in defining staged surgery in the cointerventions and how the
outcomes were defined and measured. In response to these findings, a meta-analysis was considered not appropriate. The results
showed no differences in the risk of mortality or systemic complications in young and healthy patients between simultaneous or
staged surgeries. However, increased risk of complications for staged surgeries performed during the same hospitalization was
observed. Conclusions. Available evidence is very heterogeneous and the quality of evidence is low.The available evidence supports
the performance of simultaneous hip arthroplasty in selected patients (not older than 65 years, ASA 1-2, without cardiovascular
comorbidities) and suggests the avoidance of staged surgeries within the same hospitalization.
1. Introduction
Bilateral hip disease is a frequent finding that can occur in up
to 42% of the population with osteoarthrosis [1], and it is esti-
mated that 25% of patients with osteoarthritis requiring total
hip replacementwill need a bilateral replacement [2].This has
led to the evaluation of the best strategy to operate a bilateral
hip replacement without increasing the risk of perioperative
comorbidities, having as options a simultaneous bilateral hip
replacement or a sequential surgery [3].
The implementation of simultaneous bilateral procedures
has been on the rise in recent years, arguing that it is a
procedure with potential advantages such as cost reduction
[2, 4], shorter rehabilitation time [5, 6], and shorter hospital
length of stay [5], without presenting an increased risk of
complications. Some studies have reported similar rates of
deep vein thrombosis [7], pulmonary embolism [8], infection
[9], and mortality [10] for simultaneous surgery when com-
pared with two-stage procedures. On the other hand, other
studies have shown simultaneous surgery to be associated
with an elevated risk of blood transfusion [3, 11] and some
authors recommend reserving this approach for patients with
a high preoperative hemoglobin level [6]. Furthermore, at
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